Literature DB >> 27362853

Factors Associated With Continuous Low-Dose Heparin Infusion for Central Venous Catheter Patency in Critically Ill Children Worldwide.

Sara-Jane N Onyeama1, Sheila J Hanson, Mahua Dasgupta, Raymond G Hoffmann, Edward Vincent S Faustino.   

Abstract

OBJECTIVES: To identify patient, hospital, and central venous catheter factors that may influence the use of low-dose heparin infusion for central venous catheter patency in critically ill children.
DESIGN: Secondary analysis of an international multicenter observational study.
SETTING: Fifty-nine PICUs over four study dates in 2012, involving seven countries. PATIENTS: Children less than 18 years old with a central venous catheter who were admitted to a participating unit and enrolled in the completed Prophylaxis against Thrombosis Practice study were included. All overflow patients were excluded.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Of the 2,484 patients in the Prophylaxis against Thrombosis Practice study, 1,312 patients had a central venous catheter. Five hundred seven of those patients used low-dose heparin infusion. The frequency of low-dose heparin infusion was compared across various patient, hospital, and central venous catheter factors using chi-square, Mann-Whitney U, and Fisher exact tests. In the multivariate analysis, age was not a significant factor for low-dose heparin infusion use. Patients with pulmonary hypertension had decreased low-dose heparin infusion use, whereas those with active surgical or trauma diagnoses had increased low-dose heparin infusion use. All centrally inserted central venous catheters were more likely to use low-dose heparin infusion when compared with peripherally inserted central venous catheters. The Asia-Pacific region showed increased low-dose heparin infusion use, along with community hospitals and smaller ICUs (< 10 beds).
CONCLUSIONS: Patient, central venous catheter, and hospital factors are associated with the use of low-dose heparin infusion in critically ill children. Further study is needed to evaluate the efficacy and persistence of low-dose heparin infusion use.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27362853      PMCID: PMC4980163          DOI: 10.1097/PCC.0000000000000854

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  18 in total

1.  A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study.

Authors:  Prakesh S Shah; Angela Kalyn; Prakash Satodia; Michael S Dunn; Boriana Parvez; Alan Daneman; Shia Salem; Phyllis Glanc; Arne Ohlsson; Vibhuti Shah
Journal:  Pediatrics       Date:  2007-01       Impact factor: 7.124

Review 2.  Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.

Authors:  Prakeshkumar S Shah; Vibhuti S Shah
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

3.  A multinational study of thromboprophylaxis practice in critically ill children.

Authors:  Edward Vincent S Faustino; Sheila Hanson; Philip C Spinella; Marisa Tucci; Sarah H O'Brien; Antonio Rodriguez Nunez; Michael Yung; Edward Truemper; Li Qin; Simon Li; Kimberly Marohn; Adrienne G Randolph
Journal:  Crit Care Med       Date:  2014-05       Impact factor: 7.598

4.  The effect of low-dose heparin on maintaining peripherally inserted percutaneous central venous catheters in neonates.

Authors:  S Uslu; H Ozdemir; S Comert; F Bolat; A Nuhoglu
Journal:  J Perinatol       Date:  2010-04-08       Impact factor: 2.521

5.  Survey of pharmacologic thromboprophylaxis in critically ill children.

Authors:  Edward Vincent S Faustino; Sonya Patel; Ravi R Thiagarajan; Deborah J Cook; Veronika Northrup; Adrienne G Randolph
Journal:  Crit Care Med       Date:  2011-07       Impact factor: 7.598

6.  A multicenter survey of heparin prophylaxis practice in pediatric critical care.

Authors:  Margaret Clarke; Eduardo da Cruz; Julianne Koehler; Jon Kaufman
Journal:  J Intensive Care Med       Date:  2011-03-24       Impact factor: 3.510

Review 7.  Heparin-bonded catheters for prolonging the patency of central venous catheters in children.

Authors:  Prakeshkumar S Shah; Niketa Shah
Journal:  Cochrane Database Syst Rev       Date:  2014-02-25

8.  Randomized controlled trial of heparin for prevention of blockage of peripherally inserted central catheters in neonates.

Authors:  F Kamala; N Y Boo; F C Cheah; K Birinder
Journal:  Acta Paediatr       Date:  2002       Impact factor: 2.299

9.  Prevention and management of central venous catheter occlusion and thrombosis in children with cancer.

Authors:  Roderick Skinner; Karin Koller; Nan McIntosh; Anthony McCarthy; Barry Pizer
Journal:  Pediatr Blood Cancer       Date:  2008-04       Impact factor: 3.167

Review 10.  A systematic review for effective management of central venous catheters and catheter sites in acute care paediatric patients.

Authors:  Olive Kin Eng Lee; Linda Johnston
Journal:  Worldviews Evid Based Nurs       Date:  2005       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.